Angiopoietin-like protein 4 identifies residual risk for atherothrombotic events in stable post-acute coronary syndrome patients: insights from the SPUM-ACS study
Angiopoietin-like protein 4 (ANGPTL4) regulates lipid metabolism and inflammation and has been linked to plaque vulnerability and thrombosis. However, its prognostic value in stable post-ACS patients is unclear, and clinical data on its association with recurrent atherothrombotic events, independent of traditiona...